antileukemic

Leukemic cells from patients with acute leukemia were treated with different antileukemic agents in microwell liquid culture,then the cytotoxicity was measured with MTT assay.

将白血病与化疗药物微孔液体培养，MTT法检毒性。

Minimal residual disease (MRD) as a marker of antileukemic drug efficacy is being used to assess risk status and, in some cases, to adjust the intensity of therapy.

MRD作为抗白血病药物疗效标志,被用于评患者危险,在某些病例中也用于调整治疗强。